Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [407]

Ground-breaking trial of CRISPR-edited immune cells for cancer appears safe

Ground-breaking trial of CRISPR-edited immune cells for cancer appears safe

Next-generation sequencing detects rare fusion genes in sarcoma tumours

Next-generation sequencing detects rare fusion genes in sarcoma tumours

Scientists reveal novel oncogenic driver gene in human gastrointestinal stromal tumouSarcomas - cancers that arise from transformed mesenchymal cells (a type of connective tissue) - are quite deadly. Gastrointestinal stromal tumors (GISTs) are the most co

Scientists reveal novel oncogenic driver gene in human gastrointestinal stromal tumouSarcomas - cancers that arise...

A new route to blocking children's bone cancer

A new route to blocking children's bone cancer

Breaking the 'stalemate' in the most common soft tissue sarcoma in children

Breaking the 'stalemate' in the most common soft tissue sarcoma in children

Molecule discovered that regulates the development of cancer in a variety of tumours

Molecule discovered that regulates the development of cancer in a variety of tumours

Removing cancer's protective barrier could boost immunotherapy treatments

Removing cancer's protective barrier could boost immunotherapy treatments

Chemical screening suggests a two-pronged treatment for paediatric Ewing sarcoma

Chemical screening suggests a two-pronged treatment for paediatric Ewing sarcoma

ASCO 2019: Debate-fuelling headlines you may have missed

ASCO 2019: Debate-fuelling headlines you may have missed

Cancer-killing virus boosts immunotherapy in hard-to-treat cancer

Cancer-killing virus boosts immunotherapy in hard-to-treat cancer

More from ecancer